New drug OM336 enters early human trials for autoimmune diseases
Disease control
Not yet recruiting
This early-stage trial tests a new drug called OM336 in 39 adults with active Sjogren's disease or idiopathic inflammatory myopathy. The main goal is to check the drug's safety and how the body processes it. Participants receive increasing doses of OM336 by injection under the sk…
Phase: PHASE1 • Sponsor: Ouro Medicines • Aim: Disease control
Last updated May 17, 2026 11:51 UTC